| Financial Year |
March 31 2023 |
| Monetary Funds |
5,528,431,884.51 |
| Held-for-trading Financial Assets |
220,197.14 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,326,995,819.69 |
| Advances to Suppliers |
2,137,050,414.35 |
| Other Receivables |
469,512,906.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
16,870,354,643.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,959,335,397.55 |
| Total Current Assets |
30,333,979,130.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
555,105,420.14 |
| Investment Properties |
4,308,604.25 |
| Fixed Assetes |
9,103,955,722.25 |
| Under-construction Projects |
1,971,059,102.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,741,404,497.46 |
| R&D expenses |
17,224,432.11 |
| Goodwill |
553,157,994.37 |
| Long-Term Deferred and Prepaid Expenses |
14,910,985.94 |
| Deferred Income Tax Assets |
598,780,390.21 |
| Other Non-Current Assets |
206,049,221.01 |
| Sub-Total of Non-Current Assets |
20,074,504,840.67 |
| Total Assets |
50,408,483,971.43 |
| Short-Term Loans |
11,117,490,904.93 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
5,097,869,716.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
323,093,774.73 |
| Taxes Payable |
266,772,338.60 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,048,664,201.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,977,235,829.36 |
| Other Current Liabilities |
511,947,139.26 |
| Sub-Total of Current Liabilities |
25,829,145,832.48 |
| Long-term Loans |
5,035,765,124.79 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
661,466,450.26 |
| Special Payable |
-- |
| Estimatied Liabilities |
215,200,383.12 |
| Deferred Income Tax Liabilities |
586,031,785.17 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,932,297,482.33 |
| Total Liabilities |
32,761,443,314.81 |
| Paid-In Capital(Or Share Stock) |
7,404,774,511.00 |
| Capital Surplus |
3,755,392,514.91 |
| Surplus Reserve |
186,238,818.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,445,711,882.26 |
| Minority Stockholder's Interest |
2,886,911,025.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,760,129,631.27 |
| Owner's Equity（Stockholder's Equity） |
17,647,040,656.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
50,408,483,971.43 |
